Apogee Therapeutics, Inc. APGE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $451.8M+243% | $131.55M+21.9% | $107.91M-13.1% | $124.19M+16.2% | $106.92M-24.6% | ||
| $608.09M+1.6% | $598.64M+42.7% | $419.38M+10.0% | $381.23M-6.2% | $406.41M+7.3% | ||
| $13.91M+24.6% | $11.17M-12.8% | $12.81M+19.7% | $10.7M+30.5% | $8.2M-9.5% | ||
| $1.07B+44.8% | $741.36M+37.3% | $540.1M+4.6% | $516.12M-1.0% | $521.53M-1.5% | ||
| $5.28M-7.2% | $5.69M-5.7% | $6.03M-6.3% | $6.44M+13.4% | $5.68M+190% | ||
| $7.71M-11.3% | $8.69M-9.9% | $9.65M-8.9% | $10.59M-8.0% | $11.51M+1.2% | ||
| $8.52M-1.8% | $8.67M-0.8% | $8.74M-1.3% | $8.86M+20.7% | $7.34M+1,374% | ||
| $1.29B+38.0% | $937.13M+49.7% | $626.16M-4.8% | $657.77M-7.9% | $714.16M-5.3% | ||
| $8.51M-12.4% | $9.72M+1.6% | $9.57M-16.1% | $11.41M+1.3% | $11.26M-14.2% | ||
| $3.14M-10.4% | $3.5M-14.1% | $4.08M+1.3% | $4.03M+1.2% | $3.98M+22.9% | ||
| $32.95M+18.1% | $27.91M-18.0% | $34.05M+7.9% | $31.55M-4.3% | $32.96M+15.4% | ||
| $4.91M-8.2% | $5.35M-7.4% | $5.77M-15.3% | $6.82M-13.0% | $7.84M-8.8% | ||
| $37.86M+13.9% | $33.25M-16.5% | $39.82M+3.8% | $38.37M-6.0% | $40.8M+9.8% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| $1.89B+29.2% | $1.46B+35.9% | $1.08B+3.0% | $1.05B+1.2% | $1.03B+1.1% | ||
| -$635.87M-13.2% | -$561.76M-14.1% | -$492.37M-15.2% | -$427.35M-18.3% | -$361.26M-18.1% | ||
| -$749K-169% | $1.08M+5.1% | $1.03M+50.1% | $685K-36.2% | $1.07M+17.4% | ||
| $1.29B+38.0% | $937.13M+49.7% | $626.16M-4.8% | $657.77M-7.9% | $714.16M-5.3% | ||
| $608.09M+1.6% | $598.64M+42.7% | $419.38M+10.0% | $381.23M-6.2% | $406.41M+7.3% | ||
| $8.52M-1.8% | $8.67M-0.8% | $8.74M-1.3% | $8.86M+20.7% | $7.34M+1,374% | ||
| $7.71M-11.3% | $8.69M-9.9% | $9.65M-8.9% | $10.59M-8.0% | $11.51M+1.2% | ||
| $7.71M-11.3% | $8.69M-9.9% | $9.65M-8.9% | $10.59M-8.0% | $11.51M+1.2% | ||
| $8.52M-1.8% | $8.67M-0.8% | $8.74M-1.3% | $8.86M+20.7% | $7.34M+1,374% | ||
| $7.71M-11.3% | $8.69M-9.9% | $9.65M-8.9% | $10.59M-8.0% | $11.51M+1.2% | ||
| $8.52M-1.8% | $8.67M-0.8% | $8.74M-1.3% | $8.86M+20.7% | $7.34M+1,374% | ||
| $28.58M+23.3% | $23.18M-21.7% | $29.59M— | —— | —— | ||
| $8.05M-9.1% | $8.85M-10.2% | $9.85M-9.1% | $10.85M-8.2% | $11.82M-0.1% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Apogee Therapeutics, Inc.'s total assets?
- Apogee Therapeutics, Inc. (APGE) holds $1.3B in total assets, up 81.1% year over year.
- How much cash does Apogee Therapeutics, Inc. have?
- Apogee Therapeutics, Inc. holds $451.8M in cash and equivalents.
- Can Apogee Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 32.59 — current assets exceed current liabilities.
- Where does Apogee Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.